Tazi J, Temsamani J, Alibert C, Rhead W, Khellil S, Cathala G, Brunel C, Jeanteur P
UA CNRS 1191, Laboratoire de Biochimie, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France.
Nucleic Acids Res. 1989 Jul 11;17(13):5223-43. doi: 10.1093/nar/17.13.5223.
As demonstrated by RNase T1 protection assays at 0 degrees C without ATP, U1 and U5 snRNPs purified by isopycnic centrifugation in cesium chloride bind to the 5' and 3' splice sites of human beta-globin pre-mRNA, respectively. We also devised a saturation-complementation assay and have found that this purified U5 snRNP, unlike U1, successfully competes with snRNP-free fractions of nuclear proteins which inhibit spliceosome assembly and splicing. Restoration of activity requires intact U5 snRNA and correlates with the presence of the 100 Kd intron binding protein (IBP) which we have previously characterized (Tazi et al., 1986, Cell 47, 755-766). Our results are compatible with a model in which the recognition of the 3' splice site by IBP-U5 snRNP is one of the earliest events of the spliceosome assembly. It could organize the structure of the 3' splice site region of the human beta-globin like pre-mRNAs. However, on the basis of results showing that beta-globin and major late adenovirus seem to have different requirements with respect to IBP-U5 snRNP, it appears that some pre-mRNAs could have a native structure that necessitates less if at all IBP-U5.
在0摄氏度且无ATP的条件下通过核糖核酸酶T1保护试验证明,经氯化铯密度梯度离心纯化的U1和U5核小核糖核蛋白分别与人β-珠蛋白前体mRNA的5'和3'剪接位点结合。我们还设计了一种饱和互补试验,并且发现这种纯化的U5核小核糖核蛋白与U1不同,它能成功地与抑制剪接体组装和剪接的无核小核糖核蛋白的核蛋白组分竞争。活性的恢复需要完整的U5核小核糖核酸,并且与我们之前已鉴定的100 Kd内含子结合蛋白(IBP)的存在相关(塔齐等人,1986年,《细胞》47卷,755 - 766页)。我们的结果与一种模型相符,即IBP - U5核小核糖核蛋白对3'剪接位点的识别是剪接体组装的最早事件之一。它可能会组织人β-珠蛋白样前体mRNA的3'剪接位点区域的结构。然而,基于显示β-珠蛋白和腺病毒主要晚期基因似乎对IBP - U5核小核糖核蛋白有不同需求的结果,似乎一些前体mRNA可能具有一种天然结构,这种结构对IBP - U5的需求很少甚至完全不需要。